Author:
S. Panda Sagar, ,V. V. Bera Ravi Kumar,Sahu Biswajit
Abstract
In the present study, a novel analytical procedure development concept is utilized along with a chemometrics approach. Two sensitive UV spectrophotometric methods were developed for quantifying a new antipsychotic agent, pimavanserin tartarate, in tablets. The scanning speed and sampling interval of the UV spectrophotometric methods were the critical method variables investigated and optimized by a face-centred cubic design during the development phase. A zero-order (222 nm) and a first derivative (maxima: 256 nm and minima: 283 nm) method displayed linear response over 0.5-100 µg mL-1, with impressive validation results. Further, the procedure robustness capability index was measured by using Monte Carlo simulation. In a nutshell, the present spectrophotometry based studies reveal aptness of the novel concept for developing robust and rapid analytical methods availing regulatory flexibilities for estimating pimavanserin tartarate in tablets
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference9 articles.
1. 1. Siddiqui M. R., Alothman Z.A. and Rahman N.: Analytical techniques in pharmaceutical analysis: a review, Arab. J. Chem., 2017, 10 (S1), S1409-1421.
2. 2. Deidda R., Orlandini S., Hubert P. and Hubert C.: Risk-based approach for method development in pharmaceutical quality control context: a critical review, J. Pharm. Biomed. Anal., 2018, 161, 110-121.
3. 3. Manraranjan V.C., Yadav D.S., Jogia H.A. and Chauhan P.L.: Design of experiment (DoE) utilization to develop a simple and robust reversed-phase HPLC technique for related substances estimation of omeprazole formulations, Sci. Pharm., 2013, 81(4), 1043-1056.
4. 4. Beg S., Panda S.S., Katare O.P. and Singh B.: Applications of monte-carlo simulation and chemometric techniques for development of bioanalytical liquid chromatography method for estimation of rosuvastatin calcium, J. Liq. Chromatogr. Relat. Technol., 2017, 40(18), 907-920.
5. 5. Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation: Final Concept paper Q14 International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use., 2018, 1-3.